0QBO Stock Overview
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
Coloplast A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 890.00 |
| 52 Week High | DKK 977.20 |
| 52 Week Low | DKK 740.00 |
| Beta | 0.34 |
| 11 Month Change | -0.27% |
| 3 Month Change | -2.58% |
| 1 Year Change | 18.65% |
| 33 Year Change | -24.82% |
| 5 Year Change | 10.37% |
| Change since IPO | 777.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0QBO | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -4.2% | 7.7% | -0.4% |
| 1Y | 18.6% | -2.1% | 5.6% |
Return vs Industry: 0QBO exceeded the UK Medical Equipment industry which returned -2.1% over the past year.
Return vs Market: 0QBO exceeded the UK Market which returned 5.6% over the past year.
Price Volatility
| 0QBO volatility | |
|---|---|
| 0QBO Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0QBO has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0QBO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 16,639 | Kristian Villumsen | www.coloplast.com |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
| 0QBO fundamental statistics | |
|---|---|
| Market cap | DKK 200.37b |
| Earnings (TTM) | DKK 5.05b |
| Revenue (TTM) | DKK 27.03b |
39.7x
P/E Ratio7.4x
P/S RatioIs 0QBO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0QBO income statement (TTM) | |
|---|---|
| Revenue | DKK 27.03b |
| Cost of Revenue | DKK 8.76b |
| Gross Profit | DKK 18.27b |
| Other Expenses | DKK 13.22b |
| Earnings | DKK 5.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
| Earnings per share (EPS) | 22.44 |
| Gross Margin | 67.59% |
| Net Profit Margin | 18.69% |
| Debt/Equity Ratio | 120.6% |
How did 0QBO perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield98%
Payout RatioDoes 0QBO pay a reliable dividends?
See 0QBO dividend history and benchmarks| Coloplast dividend dates | |
|---|---|
| Ex Dividend Date | Dec 06 2024 |
| Dividend Pay Date | Dec 10 2024 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 21 days |
Does 0QBO pay a reliable dividends?
See 0QBO dividend history and benchmarks